Novel approaches to support therapeutic development in ultra-rare cancers

HHS-FDA FOR-FD-26-004
Submission: Open Submission

CFDA Numbers

  • 93.103 - Food and Drug Administration Research

Additional Information

Document Type: forecast
Opportunity Category: Discretionary

Related Opportunities